tiprankstipranks
Trending News
More News >
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market

Zevra Therapeutics (ZVRA) Income Statement

Compare
1,009 Followers

Zevra Therapeutics Income Statement

Last quarter (Q3 2025), Zevra Therapeutics's total revenue was $26.06M, an increase of 605.36% from the same quarter last year. In Q3, Zevra Therapeutics's net income was $-1.41M. See Zevra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 23.61M$ 27.46M$ 10.16M$ 28.65M$ 13.29M
Gross Profit
$ 16.20M$ 24.52M$ 9.94M$ 26.59M$ 11.98M
Operating Expenses
$ 103.20M$ 74.12M$ 52.50M$ 18.86M$ 17.59M
Depreciation and Amortization
$ 6.39M$ 1.01M$ 944.00K$ 257.00K$ 273.00K
EBITDA
$ -76.40M$ -43.54M$ -25.53M$ -7.89M$ -5.43M
Operating Income
$ -87.00M$ -49.60M$ -42.56M$ 7.73M$ -5.61M
Other Income/Expenses
$ -3.14M$ 3.56M$ 15.76M$ -16.25M$ -7.18M
Pretax Income
$ -90.14M$ -46.05M$ -26.80M$ -8.52M$ -12.79M
Net Income
$ -105.51M$ -46.05M$ -26.77M$ -8.55M$ -12.76M
Per Share Metrics
Basic EPS
$ -2.28$ -1.30$ -0.78$ -2.11$ -3.21
Diluted EPS
$ -2.28$ -1.30$ -0.78$ -2.11$ -3.21
Weighted Average Shares Outstanding
46.25M 35.45M 34.49M 29.77M 3.98M
Weighted Average Shares Outstanding (Diluted)
46.25M 35.45M 34.49M 29.77M 3.98M
Currency in USD

Zevra Therapeutics Earnings and Revenue History